While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to continue.
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now. On April 13, Tom Lee, Fundstrat’s ...
Mirum's stock could skyrocket if those clinical results are positive. Some things are inherently risky. Feeding a bear while ...
Viking's candidate is part of the GLP-1 class of drugs, which interact with hormonal pathways controlling appetite and blood ...
Zacks Investment Research on MSN
Amgen (AMGN) laps the stock market: Here's why
In the latest close session, Amgen (AMGN) was up +1.69% at $355.30. This move outpaced the S&P 500's daily gain of 1.2%. Elsewhere, the Dow gained 1.79%, while the tech-heavy Nasdaq added 1.52%. Prior ...
Revolution Medicines (RVMD) is one of the best stocks on Wall Street today after breakthrough cancer pill results ...
Investor's Business Daily on MSN
Stock market today: Dow dips on Trump Iran move; biotech plays, these software stocks shine (live coverage)
Stock Market Today: The Dow Jones fell on President Trump's latest Iran move. Software stocks and biotech shined but Goldman Sachs fell.
These companies will offer you the fantastic combination of growth and safety. They're both trading at reasonable prices right now. 10 stocks we like better than Regeneron Pharmaceuticals › Biotech ...
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results